Skip to main content
. 2009 Jun 9;338:b2175. doi: 10.1136/bmj.b2175

Table 3.

 Prevalence of genetic discrimination experiences reported by 233 asymptomatic people at risk for Huntington’s disease by genetic testing and test result. Values are numbers (percentages) unless stated otherwise

Setting of discrimination Total (n=233) Genetically tested Not tested (n=66) P value of difference
Total (n=167) Positive test (n=83) Negative test (n=84) Total tested v not tested* Positive test v negative test* Overall†
Overall 93 (39.9) 71 (42.5) 42 (50.6) 29 (34.5) 22 (33.3) 0.236 0.042 0.046
Insurance 68 (29.2) 53 (31.7) 31 (37.3) 22 (26.2) 15 (22.7) 0.202 N/A 0.112
Family 36 (15.5) 31 (18.6) 19 (22.9) 12 (14.3) 5 (7.6) 0.044‡ 0.168 0.034§
Social 29 (12.4) 25 (15.0) 17 (20.5) 8 (9.5) 4 (6.1) 0.078 0.053 0.018¶
Employment 16 (6.9) 15 (9.0) 12 (14.5) 3 (3.6) 1 (1.5) —** 0.003†† 0.003††
Health care 20 (8.6) 14 (8.4) 11 (13.3) 3 (3.6) 6 (9.1) 0.802 N/A 0.081
Public sector 9 (3.9) 9 (5.4) 5 (6.0) 4 (4.8) 0 (0.0) —** —** —**

*Fisher’s exact test. Values are two sided.

†Positive test v negative test v not tested. Pearson’s χ2 test. Values are two sided.

N/A: post hoc comparison is not applicable as primary comparison was not significant (see corresponding overall P value).

‡P value did not reach the required significance level adjusted for false discovery rate (P≤0.014).

§Post hoc P value (positive test v not tested, P=0.013) was above the required significance level adjusted for false discovery rate (P≤0.007).

¶Post hoc P value (positive test v not tested, P=0.016) was above the required significance level adjusted for false discovery rate (P≤0.011).

**Assumptions of the χ2 test not met.

††Post hoc P values (positive test v not tested, P=0.007; negative test v not tested, P=0.016) were above the required significance levels adjusted for false discovery rate (P≤0.005 and P≤0.010, respectively).